Vivo Bio Tech Fair Value
Vivo Bio Tech fair value. Vivo Bio Tech (VIVOBIOT) average fair value is ₹82.34 across 8 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Earnings Growth Model (PEG), Peter Lynch Fair Value, Benjamin Graham Number, Discounted Cash Flow (DCF), vs a current market price of ₹14.32 (+475.03%), fair value range ₹1.29–₹428.9. Analyse Vivo Bio Tech shareholding analysis to track promoter, FII and institutional holdings.
Fair Value Analysis Export
VIVOBIOT Fair Value vs Current Price — Valuation Summary
VIVOBIOT average fair value, fair value range, price gap and valuation status across 8 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Earnings Growth Model (PEG), Peter Lynch Fair Value, Benjamin Graham Number, Discounted Cash Flow (DCF). For live price and a broader fundamental view, visit VIVOBIOT share price screener.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Earnings Growth Model (PEG)
Peter Lynch Fair Value
Benjamin Graham Number
Discounted Cash Flow (DCF)
VIVOBIOT Fair Value Analysis — Data Sources & Coverage
Vivo Bio Tech financial data sources, valuation methods applied and sector benchmarks used — 2026 financial year.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
Data Currency: Financial data is from the current year (2026).
VIVOBIOT vs Healthcare Sector Peers — P/E, P/B & Market Cap
Vivo Bio Tech P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Emcure Pharmaceuticals | EMCURE | 40.6 | 8.3 | ₹44,381 |
| Modern Diagnostic & Rese… | MDRC | - | 1.42 | ₹83 |
| Pharmaids Pharmaceuticals | PHARMAID | -28.7 | 2.2 | ₹100 |
| Glen Industries | GLEN | 15.7 | 1.97 | ₹250 |
| Broach Lifecare Hospital | BROACH | 90.7 | 0.82 | ₹8 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.